Proinsulin ELISA
MercodiaProinsulin ELISA is a method for the quantitative determination of human proinsulin in serum or plasma.
Enzyme-linked immunosorbent assays (ELISA), also known as enzyme immunoassays (EIA), are used for the detection and quantification of proteins, peptides and antibodies in a sample. ELISA often comes in kit format, with pre-selected antibody pairs to detect specific proteins or biomarkers of diseases such as diabetes and obesity, or cardiovascular and neurological disorders. Detection is made possible with chemiluminescent, fluorescent or colorimetric substrates and detection instruments such as microplate / ELISA readers. Other kits available include: Enzyme-linked immunospot (ELISPOT) assays for the quantification of protein-producing cells and chemiluminescent immunoassays (CLIA) kits. Find the best ELISA kits and products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.
Proinsulin ELISA is a method for the quantitative determination of human proinsulin in serum or plasma.
Mercodia Total GLP-1 NL-ELISA provides a chemiluminescent method for the quantitative determination of amidated GLP-1 (1-36) in human serum or plasma samples. The assay has been validated according to CLSI, FDA and EMA guidelines.
The Mercodia Total GIP NL-ELISA provides a method for the quantitative determination of GIP in human samples. Mercodia Total GIP NL-ELISA measures active GIP(1-42) to the same extent as its metabolite GIP(3-42). Thus, the rapid degradation of the active GIP(1-42) form is not a problem for the specificity of the assay. Accurate results are obtained even if samples without any stabilizing additives are analyzed.
Mercodia Lispro NL-ELISA is designed to be an excellent assay for pharma use. It provides a chemiluminescent method for the quantitative determination of insulin lispro. The kit includes six calibrators, two anchor points and controls in serum matrix. Validation data available.
Our unique combination of custom antibody development, lateral flow development and manufacturing services, signal enhancement technology and our mobile diagnostic platform are shaping the future of lateral flow. Our partnership approach allows you to work with one company to reach your assay goals.
Discover our breadth of experience and be reassured that our Lateral Flow Development Services will deliver the best outcome for your assay.
BBI Solutions has over 25 years’ expertise working with customers and partners to develop and manufacture high quality proteins for a diverse range of applications with our Custom Protein Service.
BBI’s custom conjugation service allows us to develop high-quality conjugates using reagents provided by you or sourced by us.
BBI Solutions’ Novarum™ technology transforms a smartphone into a mobile diagnostic platform, empowering users to read and share the results of rapid tests at the point of care.
A high quality enzyme immunoassay for specific quantification of human insulin in serum or plasma. The Mercodia insulin assays have little or no cross-reactivity to insulin analogs, rat or mouse insulin, which enables distinguishing endogenous human insulin, both in patients undergoing treatment with insulin analogs, and in rat or mouse models. The Mercodia Insulin ELISAs are the only ELISA assays to satisfy the total error r…
Enzyme Immunoassay for the Qualitative / Quantitative Screening of double stranded RNA in mRNA based preparations.
Immunoassay for the measurement of E.coli Host Cell Proteins
ELISA for the detection of Blinatumomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
Enzyme Immunoassay for the Quantitative Determination of Faricimab in human serum and plasma.
Enzyme Immunoassay for the quantitative determination of Ocrelizumab in serum and plasma.
Enzyme Immunoassay for the quantitative determination of Pidilizumab in serum and plasma.
Enzyme Immunoassay for the Quantitative Determination of Relatlimab in human serum and plasma
Enzyme Immunoassay for the Quantitative Determination of Teclistamab in serum and plasma
Enzyme Immunoassay for the quantitative determination of Erenumab in serum and plasma.
Enzyme Immunoassay for the quantitative determination of Guselkumab in serum and plasma.
Enzyme Immunoassay for the Quantitative Determination of Cemiplimab in human serum and plasma
Enzyme Immunoassay for the Quantitative Determination of Amivantamab in serum and plasma
Canakinumab (ILARIS) ELISA for quantitative determination of Canakinumab (ILARIS) in human serum
Enzyme Immunoassay for the Quantitative Determination of Teprotumumab in serum and plasma.